ArriVent BioPharma Insider Trades
NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 1 · $12.98M
- Shares bought / sold
- 0 / 555.55K
- Net activity
- Net selling $13.0 million
ArriVent BioPharma insider activity
Over the last 12 months, ArriVent BioPharma insiders reported 6 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $13.0 million worth of stock, for net insider selling of $13.0 million. The largest seller was HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD., with $13.0 million in reported sales.
The most recent filing shows LaChapelle Robin (Chief Operating Officer) reporting a transaction in 16,265 shares at $3.65 on Oct 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AVBP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AVBP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 30, 2026 | LaChapelle RobinChief Operating Officer | Option exercise | 17,648 | $110.05K | Form 4 |
| Oct 30, 2026 | LaChapelle RobinChief Operating Officer | Option exercise | 1,820 | $4.15K | Form 4 |
| Oct 30, 2026 | LaChapelle RobinChief Operating Officer | Option exercise | 4,550 | $10.38K | Form 4 |
| Oct 30, 2026 | LaChapelle RobinChief Operating Officer | Option exercise | 410 | $935.42 | Form 4 |
| Oct 30, 2026 | LaChapelle RobinChief Operating Officer | Option exercise | 16,265 | $59.37K | Form 4 |
| Dec 10, 2025 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% Owner | Sale | 555,555 | $12.98M | Form 4 |
| Jul 11, 2025 | LaChapelle RobinChief Operating Officer | Option exercise | 6,503 | $14.83K | Form 4 |
| Jul 11, 2025 | LaChapelle RobinChief Operating Officer | Option exercise | 2,600 | $5.93K | Form 4 |
| Jul 11, 2025 | LaChapelle RobinChief Operating Officer | Option exercise | 2,050 | $4.67K | Form 4 |
| Sep 19, 2024 | LaChapelle RobinChief Operating Officer | Option exercise | 12,364 | $45.13K | Form 4 |
| Sep 19, 2024 | LaChapelle RobinChief Operating Officer | Option exercise | 2,471 | $5.63K | Form 4 |
| Sep 19, 2024 | LaChapelle RobinChief Operating Officer | Option exercise | 7,164 | $16.33K | Form 4 |
| Sep 19, 2024 | LaChapelle RobinChief Operating Officer | Option exercise | 2,867 | $6.54K | Form 4 |
| Sep 19, 2024 | LaChapelle RobinChief Operating Officer | Option exercise | 2,700 | $16.85K | Form 4 |
| Jan 30, 2024 | HEALY JAMESDirector | Buy | 444,444 | $8.00M | Form 4 |
| Jan 30, 2024 | HEALY JAMESDirector | Conversion | 1,252,308 | — | Form 4 |
| Jan 30, 2024 | GORDON CARL LDirector | Buy | 222,222 | $4.00M | Form 4 |
| Jan 30, 2024 | GORDON CARL LDirector | Buy | 222,222 | $4.00M | Form 4 |
| Jan 30, 2024 | GORDON CARL LDirector | Conversion | 469,615 | — | Form 4 |
| Jan 30, 2024 | GORDON CARL LDirector | Conversion | 469,615 | — | Form 4 |
| Jan 30, 2024 | GORDON CARL LDirector | Conversion | 821,827 | — | Form 4 |
| Jan 30, 2024 | GORDON CARL LDirector | Conversion | 821,827 | — | Form 4 |
| Jan 30, 2024 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.Director | Buy | 222,222 | $4.00M | Form 4 |
| Jan 30, 2024 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.Director | Buy | 222,222 | $4.00M | Form 4 |
| Jan 30, 2024 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.Director | Conversion | 469,615 | — | Form 4 |
| Jan 30, 2024 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.Director | Conversion | 469,615 | — | Form 4 |
| Jan 30, 2024 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.Director | Conversion | 821,827 | — | Form 4 |
| Jan 30, 2024 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.Director | Conversion | 821,827 | — | Form 4 |
| Jan 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% Owner | Buy | 555,555 | $10.00M | Form 4 |
| Jan 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% Owner | Conversion | 313,076 | — | Form 4 |
| Jan 30, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% Owner | Conversion | 3,616,041 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4